Both IGH and RHOH are highly expressed in normal B cells, indicating that the merger of the BCL6 SS domain with SE regions represents a potential functional explanation for the aberrant upregulation of BCL6 in B-cell lymphoma. This evidence concerns the gene BCL6 and B-cell non-Hodgkin lymphoma.